撒哈拉以南非洲地区地理和交通相关障碍对艾滋病毒治疗结果的影响：系统评价。
Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review.
机构信息
Departments of Internal Medicine and Pediatrics, University of Pennsylvania, Philadelphia, PA, USA,
出版信息
AIDS Behav. 2014 Jul;18(7):1199-223. doi: 10.1007/s10461-014-0729-8.
Abstract
Difficulty obtaining reliable transportation to clinic is frequently cited as a barrier to HIV care in sub-Saharan Africa (SSA). Numerous studies have sought to characterize the impact of geographic and transportation-related barriers on HIV outcomes in SSA, but to date there has been no systematic attempt to summarize these findings. In this systematic review, we summarized this body of literature. We searched for studies conducted in SSA examining the following outcomes in the HIV care continuum: (1) voluntary counseling and testing, (2) pre-antiretroviral therapy (ART) linkage to care, (3) loss to follow-up and mortality, and (4) ART adherence and/or viral suppression. We identified 34 studies containing 52 unique estimates of association between a geographic or transportation-related barrier and an HIV outcome. There was an inverse effect in 23 estimates (44 %), a null association in 26 (50 %), and a paradoxical beneficial impact in 3 (6 %). We conclude that geographic and transportation-related barriers are associated with poor outcomes across the continuum of HIV care.
摘要
在撒哈拉以南非洲（SSA），难以获得可靠的交通工具前往诊所经常被认为是艾滋病护理的障碍。许多研究都试图描述地理和交通相关障碍对 SSA 中艾滋病毒结果的影响，但迄今为止，还没有人系统地试图总结这些发现。在本系统评价中，我们总结了这部分文献。我们搜索了在 SSA 进行的研究，以了解 HIV 护理连续体中的以下结果：（1）自愿咨询和检测，（2）抗逆转录病毒治疗（ART）前与护理的联系，（3）失访和死亡，以及（4）ART 依从性和/或病毒抑制。我们确定了 34 项研究，其中包含 52 项关于地理或交通相关障碍与艾滋病毒结果之间关联的独特估计。在 23 项估计中有负效应（44%），26 项无关联（50%），3 项有相反的有益影响（6%）。我们的结论是，地理和交通相关的障碍与艾滋病毒护理连续体中的不良结果有关。
相似文献
1
Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review.撒哈拉以南非洲地区地理和交通相关障碍对艾滋病毒治疗结果的影响：系统评价。
AIDS Behav. 2014 Jul;18(7):1199-223. doi: 10.1007/s10461-014-0729-8.
2
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
3
Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review.撒哈拉以南非洲地区抗逆转录病毒药物用于预防母婴传播的采用障碍和促进因素：系统评价。
J Int AIDS Soc. 2013 Jul 19;16(1):18588. doi: 10.7448/IAS.16.1.18588.
4
Examining barriers to antiretroviral therapy initiation in infants living with HIV in sub-Saharan Africa despite the availability of point-of-care diagnostic testing: a narrative systematic review.尽管已有床边诊断检测，但在撒哈拉以南非洲地区，仍有许多感染艾滋病毒的婴儿无法开始接受抗逆转录病毒治疗：一项叙述性系统评价。
J Int AIDS Soc. 2024 Jul;27 Suppl 1(Suppl 1):e26284. doi: 10.1002/jia2.26284.
5
Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.定量分析并解决撒哈拉以南非洲地区艾滋病毒感染者护理连续体中的损失：系统评价。
J Int AIDS Soc. 2012 Nov 19;15(2):17383. doi: 10.7448/IAS.15.2.17383.
6
Male partners' involvement in prevention of mother-to-child HIV transmission in sub-Saharan Africa: A systematic review.男性伴侣参与撒哈拉以南非洲地区预防母婴传播艾滋病毒的情况：一项系统评价。
SAHARA J. 2015;12:87-105. doi: 10.1080/17290376.2015.1123643.
7
HIV care and treatment experiences among female sex workers living with HIV in sub-Saharan Africa: A systematic review.撒哈拉以南非洲感染艾滋病毒的女性性工作者的艾滋病毒护理与治疗经历：一项系统综述
Afr J AIDS Res. 2016 Dec;15(4):377-386. doi: 10.2989/16085906.2016.1255652.
8
Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.3岁以下HIV感染儿童抗逆转录病毒疗法的优化
Cochrane Database Syst Rev. 2014 May 22;2014(5):CD004772. doi: 10.1002/14651858.CD004772.pub4.
9
Decentralising HIV treatment in lower- and middle-income countries.在低收入和中等收入国家分散艾滋病病毒治疗工作。
Cochrane Database Syst Rev. 2013 Jun 27;2013(6):CD009987. doi: 10.1002/14651858.CD009987.pub2.
10
Magnitude and characteristics of unsuppressed HIV viral load in children and adolescents on antiretroviral therapy in sub-Saharan Africa: a systematic review and meta-analysis.撒哈拉以南非洲接受抗逆转录病毒治疗的儿童和青少年中未抑制的艾滋病毒病毒载量的大小和特征：一项系统评价和荟萃分析。
Lancet HIV. 2025 Jul;12(7):e506-e521. doi: 10.1016/S2352-3018(25)00039-6. Epub 2025 Jun 2.
引用本文的文献
1
Patient related factors associated with antiretroviral therapy defaulting among the youth accessing HIV care services in Mzimba, Malawi.在马拉维姆津巴接受艾滋病毒护理服务的青年中，与抗逆转录病毒治疗脱漏相关的患者因素。
PLOS Glob Public Health. 2025 Jul 31;5(7):e0004507. doi: 10.1371/journal.pgph.0004507. eCollection 2025.
2
Analysis of travel-time to HIV treatment in sub-Saharan Africa reveals inequities in access to antiretrovirals.对撒哈拉以南非洲地区获得艾滋病治疗所需时间的分析揭示了在获取抗逆转录病毒药物方面的不平等现象。
Commun Med (Lond). 2025 May 12;5(1):169. doi: 10.1038/s43856-025-00890-y.
3
Extreme geographic misalignment of healthcare resources and HIV treatment deserts in Malawi.马拉维医疗资源的极度地理分布不均与艾滋病毒治疗荒漠
Nat Med. 2025 May;31(5):1474-1483. doi: 10.1038/s41591-025-03561-6. Epub 2025 Mar 14.
4
From policy to practice: syndemic and intersectional challenges to ART adherence for transgender women under India's post-test and treat policy.从政策到实践：印度检测后治疗政策下，跨性别女性在坚持抗逆转录病毒治疗方面面临的综合征和交叉性挑战
Glob Public Health. 2025 Dec;20(1):2473446. doi: 10.1080/17441692.2025.2473446. Epub 2025 Mar 6.
5
Using an app for COVID-19 contact tracing costs less per person traced than manual tracing: microcosting analysis of a randomised trial in Cameroon.使用应用程序进行新冠病毒接触者追踪的人均成本低于人工追踪：喀麦隆一项随机试验的微观成本分析
BMJ Public Health. 2025 Jan 21;2(Suppl 1):e001064. doi: 10.1136/bmjph-2024-001064. eCollection 2024 Jul.
6
Feasibility of a Mobile Application for Self and Assisted Reporting of Coronavirus Disease 2019 Self-Testing Results in Tanzania: A Pilot Study.坦桑尼亚一款用于自我报告和辅助报告2019冠状病毒病自我检测结果的移动应用程序的可行性：一项试点研究。
Am J Trop Med Hyg. 2025 Feb 25;112(6):1280-1288. doi: 10.4269/ajtmh.24-0161. Print 2025 Jun 4.
7
Out-of-Catchment Area Antiretroviral Therapy Initiation and its Factors among HIV Positive People on Lifelong Therapy in Western Ethiopia: Implementation of Decentralized ART Services.埃塞俄比亚西部接受终身治疗的HIV阳性患者的跨区域抗逆转录病毒治疗启动情况及其影响因素：分散式抗逆转录病毒治疗服务的实施
J Int Assoc Provid AIDS Care. 2025 Jan-Dec;24:23259582241307467. doi: 10.1177/23259582241307467.
8
Bolstering Access to HIV-Related Health care in Zimbabwe Among Young Mothers Living With HIV: Lessons Learned on HIV Health Promotion From Zvandiri's Young Mentor Mother Program.加强津巴布韦感染艾滋病毒的年轻母亲获得与艾滋病毒相关医疗保健的机会：从兹万迪里的年轻指导母亲项目中吸取的艾滋病毒健康促进经验教训。
Health Promot Pract. 2024 Sep 30;26(4):15248399241278974. doi: 10.1177/15248399241278974.
9
Characterizing HIV Acquisition Risk, Treatment Gaps, and Populations Reached Through Venue-Based Outreach and Clinical Services in Blantyre, Malawi: Findings From a District-wide CLOVE Study.在马拉维布兰太尔通过基于场所的外展服务和临床服务来描述艾滋病毒感染风险、治疗差距及覆盖人群：一项全区范围的CLOVE研究结果
J Acquir Immune Defic Syndr. 2024 Dec 1;97(4):315-324. doi: 10.1097/QAI.0000000000003493.
10
Risk factors for infertility and barriers to treatment in Tanzania: a survey and medical records study.坦桑尼亚不孕的风险因素和治疗障碍：一项调查和病历研究。
Afr Health Sci. 2023 Dec;23(4):462-471. doi: 10.4314/ahs.v23i4.50.
本文引用的文献
1
Adherence to antiretroviral therapy among HIV-infected children attending a donor-funded clinic at a tertiary hospital in Nigeria.尼日利亚一家三级医院中由捐赠资金资助的诊所里，感染艾滋病毒儿童对抗逆转录病毒疗法的依从性。
Afr J AIDS Res. 2010 Apr;9(1):25-30. doi: 10.2989/16085906.2010.484543.
2
Harnessing poverty alleviation to reduce the stigma of HIV in Sub-Saharan Africa.利用扶贫来减少撒哈拉以南非洲地区艾滋病毒的耻辱感。
PLoS Med. 2013 Nov;10(11):e1001557. doi: 10.1371/journal.pmed.1001557. Epub 2013 Nov 26.
3
Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis.艾滋病相关耻辱感对治疗依从性的影响：系统评价与综合分析
J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18640. doi: 10.7448/IAS.16.3.18640.
4
Feasibility and Acceptability of a Real-Time Adherence Device among HIV-Positive IDU Patients in China.中国HIV阳性注射吸毒患者中实时依从性监测设备的可行性和可接受性
AIDS Res Treat. 2013;2013:957862. doi: 10.1155/2013/957862. Epub 2013 Jul 16.
5
Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda.实时监测乌干达农村地区感染艾滋病毒的成年和儿童患者抗逆转录病毒治疗的依从性。
AIDS. 2013 Aug 24;27(13):2166-8. doi: 10.1097/QAD.0b013e328363b53f.
6
Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda.乌干达农村地区的内化耻辱感、社会距离与艾滋病毒血清阳性状况的披露
Ann Behav Med. 2013 Dec;46(3):285-94. doi: 10.1007/s12160-013-9514-6.
7
GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda.GPS 测量的诊所距离，而不是自我报告的交通因素，与乌干达农村地区的 HIV 诊所就诊失约相关。
AIDS. 2013 Jun 1;27(9):1503-8. doi: 10.1097/QAD.0b013e32835fd873.
8
The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting.在公共卫生环境中，对 CD4 计数大于 500/μL 的开始接受治疗的 HIV 感染者提出“普遍抗逆转录病毒治疗”建议对 HIV RNA 水平的影响。
Clin Infect Dis. 2012 Dec;55(12):1690-7. doi: 10.1093/cid/cis750. Epub 2012 Sep 5.
9
Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review.艾滋病病毒抗逆转录病毒治疗衔接的风险因素、障碍和促进因素：系统评价。
AIDS. 2012 Oct 23;26(16):2059-67. doi: 10.1097/QAD.0b013e3283578b9b.
10
Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs.重新思考治疗前咨询中的“前”：在乌干达人开始接受抗逆转录病毒治疗时，治疗前额外访视并不能提高治疗依从性或降低病毒载量。
PLoS One. 2012;7(6):e39894. doi: 10.1371/journal.pone.0039894. Epub 2012 Jun 26.
Zotero 插件